Advertisement

Hepatology International

, Volume 13, Issue 4, pp 399–402 | Cite as

Association of acute-on-chronic liver failure with vascular liver diseases

  • Akash ShuklaEmail author
  • Abhinav Jain
Point-of-View

Introduction

Acute-on-chronic liver failure (ACLF) is defined as acute hepatic insult manifesting as jaundice and coagulopathy, complicated within 4 weeks by clinical ascites and/or encephalopathy in a patient with previously diagnosed or undiagnosed chronic liver disease/cirrhosis, and is associated with a high 28-day mortality [1]. Budd–Chiari syndrome and portal vein thrombosis (PVT) are two commonest vascular liver disorders but their association with ACLF has not been systematically evaluated. In patients with ACLF with acute event of venous thrombosis like PVT or hepatic vein thrombosis, there is a potential for reversibility of liver failure. We believe that all attempts need to be made towards urgent recanalization of the recently thrombosed vein(s) especially in the ‘golden window’ to achieve this reversibility. This article presents the personal point of view of the authors regarding the possible associations, pathological basis, clinical impact and management strategies of...

Notes

Compliance with ethical standards

Human and animal rights

This article does not contain any studies with human or animal subjects.

References

  1. 1.
    Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, et al. APASL ACLF Working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2014;8:453–71.CrossRefPubMedGoogle Scholar
  2. 2.
    Trebicka J. Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close? J Hepatol. 2017;66:442–50.CrossRefPubMedGoogle Scholar
  3. 3.
    Yin S, Wang SJ, Gu WY, Zhang Y, Chen LY, Li H. Risk of different precipitating events for progressing to acute-on-chronic liver failure in HBV-related cirrhotic patients. J Dig Dis. 2017;18:292–301.CrossRefPubMedGoogle Scholar
  4. 4.
    Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16:6046–57.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Langlet P, Escolano S, Valla D, Coste-Zeitoun D, Denie C, Mallet A, et al. Clinicopathological forms and prognostic index in Budd–Chiari syndrome. J Hepatol. 2003;39:496–501.CrossRefPubMedGoogle Scholar
  6. 6.
    Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, et al. TIPS for acute and chronic Budd–Chiari syndrome: a single-centre experience. J Hepatol. 2003;38(6):751–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Radha Krishna Y, Saraswat VA, Das K, Himanshu G, Yachha SK, Aggarwal R, Choudhuri G. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int. 2009;29(3):392–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Wong RKM, Wai CT. A bolt out of the blue: a case of unexpected acute liver failure. Ann Acad Med Singap. 2006;35:504–7.PubMedGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2019

Authors and Affiliations

  1. 1.Department of GastroenterologyLTMMC & LTMGHSion, MumbaiIndia
  2. 2.CIMS HospitalAhmedabadIndia

Personalised recommendations